FDA Classifies Integrated Continuous Glucose Monitoring System as Class II Device with Special Controls

Summary

The FDA has classified the integrated continuous glucose monitoring system as a Class II device with special controls, aiming to ensure its safety and effectiveness while enhancing patients' access to innovative devices.